Objectives: Mechanical ventilation is a lifesaving measure for patients with respiratory failure. However, prolonged mechanical ventilation results in diaphragm weakness, which contributes to problems in weaning from the ventilator. Therefore, identifying the signaling pathways responsible for mechanical ventilationinduced diaphragm weakness is essential to developing effective countermeasures to combat this important problem. In this regard, the forkhead boxO family of transcription factors is activated in the diaphragm during mechanical ventilation, and forkhead boxO-specific transcription can lead to enhanced proteolysis and muscle protein breakdown. Currently, the role that forkhead boxO activation plays in the development of mechanical ventilation-induced diaphragm weakness remains unknown. Design: This study tested the hypothesis that mechanical ventilation-induced increases in forkhead boxO signaling contribute to ventilator-induced diaphragm weakness. Setting: University research laboratory. Subjects: Young adult female Sprague-Dawley rats. Interventions: Cause and effect was determined by inhibiting the activation of forkhead boxO in the rat diaphragm through the use of a dominant-negative forkhead boxO adeno-associated virus vector delivered directly to the diaphragm. Measurements and Main Results: Our results demonstrate that prolonged (12 hr) mechanical ventilation results in a significant decrease in both diaphragm muscle fiber size and diaphragmspecific force production. However, mechanically ventilated animals treated with dominant-negative forkhead boxO showed a significant attenuation of both diaphragm atrophy and contractile dysfunction. In addition, inhibiting forkhead boxO transcription attenuated the mechanical ventilation-induced activation of the ubiquitin-proteasome system, the autophagy/lysosomal system, and caspase-3. Conclusions: Forkhead boxO is necessary for the activation of key proteolytic systems essential for mechanical ventilation-induced diaphragm atrophy and contractile dysfunction. Collectively, these results suggest that targeting forkhead boxO transcription could be a key therapeutic target to combat ventilator-induced diaphragm dysfunction. (Crit Care Med 2015; 43:e133-e142) 
M echanical ventilation (MV) is used clinically to provide sufficient alveolar ventilation in patients incapable of maintaining adequate pulmonary gas exchange. Although MV can be a lifesaving intervention for patients with acute respiratory failure, prolonged MV results in the rapid development of ventilator-induced diaphragm dysfunction (VIDD), which occurs as a result of diaphragm atrophy and contractile dysfunction (1) (2) (3) . From a clinical perspective, VIDD is important because respiratory muscle weakness is a contributing factor that can predict potential difficulties in weaning patients from the ventilator (4) . Weaning difficulties are a dilemma in critical care medicine as 20-30% of mechanically ventilated patients experience weaning problems (5) . Therefore, understanding the mechanism(s) leading to MV-induced diaphragm weakness is a critical step toward developing a therapeutic intervention to prevent VIDD.
The development of VIDD occurs rapidly as a result of decreased protein synthesis and increased proteolysis (6, 7) . However, because of the rapid development of VIDD, MV-induced increases in diaphragm protein breakdown appear to play the dominant role (3) . All four primary proteolytic systems are activated in the diaphragm during MV (i.e., calpain, caspase-3, ubiquitin-proteasome system, and the autophagy/ lysosomal system) (8) (9) (10) . However, the trigger signaling the activation of each of these pathways during atrophy conditions remains unknown. In this regard, the forkhead boxO (FOXO) family of transcriptions factors are activated in the diaphragm during MV and appear to control skeletal muscle mass through the regulation of muscle atrophy-related genes (i.e., MuRF1, Atrogin-1/MaFbx, LC3, and BNIP3). Recent evidence suggests that prolonged MV activates the FOXO family of transcription factors in the diaphragm. Specifically, studies in both humans and animals report that prolonged MV results in an up-regulation of FOXO signaling (e.g., FOXO1 and FOXO3) in the diaphragm (8, 11, 12) . However, whether FOXO activation is required for the development of VIDD remains unknown.
Therefore, this study tested the hypothesis that MV-induced increased FOXO transcription in the diaphragm is a requirement for the development of VIDD. Cause and effect was determined by delivering a dominant-negative FOXO (dnFOXO) adeno-associated virus (AAV) vector directly into the diaphragm to inhibit FOXO-specific transcription to elucidate the role that increased FOXO activity plays in the development of VIDD.
METHODS

Animals and Experimental Design
Young adult (~6 mo old) female Sprague-Dawley rats were randomly assigned to the following groups (n = 8/group): 1) acutely anesthetized control with green fluorescent protein (GFP); 2) acutely anesthetized control with dnFOXO-GFP; 3) 12 hours of MV with GFP; and 4) 12 hours of MV with dnFOXO-GFP. The Institutional Animal Care and Use Committee of the University of Florida approved these experiments.
Packaging and Purification of Recombinant AAV Vectors
The dnFOXO plasmid was a gift of Dr. Andrew Judge (University of Florida, Gainesville) and has been previously described (13) . Specifically, the dnFOXO consists of only the DNA-binding domain of FoxO3a (aa 141-266), which allows it to bind to DNA but not activate transcription. Because of the significant homology between the FOXO-DNA binding domains of the FOXO factors, this construct also has the potential to repress FOXO1-and FOXO4-dependent transcription (14) (15) (16) . The GFP-expressing empty vector, pTRUF12-GFP, was used as a control plasmid for both the acutely anesthetized control group and the 12 hours of MV group. The rAAV9 pTRUF12-dnFOXO-GFP and pTRUF12-GFP were generated, purified, and tittered at the University of Florida Gene Therapy Center Vector Core Lab as previously described (17) .
Real-time polymerase chain reaction (PCR) was used to verify expression of the dnFOXO construct in pTRUF12-dnFOXO-GFP-treated animals compared with control animals. In addition, Western blots for GFP were performed to verify the presence of the constructs in all animals (data not shown).
Experimental Protocol
Surgical Protocol. To prevent MV-induced activation of FOXO transcription in the diaphragm, we delivered an AAV vector containing dnFOXO to the costal diaphragm via direct injection. This innovative technique is described in a recent report (18) . Specifically, this method of gene transfer was reported to effectively transduce the rat diaphragm with no adverse side effects (18) .
MV. Control animals were acutely anesthetized with sodium pentobarbital (60 mg/kg body weight intraperitoneally). MV animals were tracheostomized and mechanically ventilated with a pressure-controlled ventilator (Servo Ventilator 300, Siemens, Munich, Germany) for 12 hours as previously reported (19) .
Biochemical Measures
Western Blot Analysis. Diaphragm protein extracts were assayed as previously described (20) . Membranes were probed for GFP (sc-8334), Bcl-2 (ab7973), cleaved caspase-3 (ab1136812) (Abcam, Cambridge, MA), caspase-3 (#9665), beclin-1 (#3738), LC3B (#2775) (Cell Signaling Technology, Carlsbad, CA), cytochrome c (sc-7159), and α-tubulin (sc-58667) (Santa Cruz Biotechnology, Santa Cruz, CA).
Real-Time PCR. One microliter of complementary DNA was added to a 25 μL PCR reaction for real-time PCR using Taqman chemistry and the ABI Prism 7000 Sequence Detection system (ABI, Foster City, CA) as previously described (20) .
20S Proteasome Activity. The in vitro chymotrypsin-like activity of the 20S proteasome was measured fluorometrically (20) .
Cathepsin L Activity. Cathepsin L activity was measured fluorometrically according to manufacturer's instructions (Abcam). Measurement of In Vitro Diaphragmatic Contractile Properties. Upon euthanization of rats, diaphragm contractile properties were measured as previously described (2) .
Mitochondrial Respiration. Mitochondrial oxygen consumption was measured in isolated mitochondria from diaphragm muscle using previously described techniques (21) . The respiratory control ratio (RCR) was calculated by dividing state 3 by state 4 respiration.
Histological Measures
Electron Microscopy. Diaphragm samples were treated and prepared for electron microscopy examination and analyzed by the University of Florida ICBR Electron Microscopy Core Lab.
GFP Staining. Sections were directly imaged using an inverted fluorescent microscope to visualize GFP expression using a ×10 objective lens.
Myofiber Cross-Sectional Area. Sections from frozen diaphragm samples were cut at 10 μm using a cryotome (Shandon, Pittsburgh, PA) and stained as described previously (19) . Cross-sectional area (CSA) was determined using Scion software (NIH, Bethesda, MD). LC3 Immunohistochemistry. Diaphragm sections were stained using LC3 primary (Cell Signaling Technology) and secondary (Alexa Fluro 488 goat anti-rabbit) reagents diluted in 1% bovine serum albumin.
Apoptosis. The terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) method was employed using a histochemical fluorescent detection kit (Roche Applied Scientific, Indianapolis, IN).
Statistical Analysis
Comparisons between groups for each dependent variable were made by a one-way analysis 
RESUlTS
Systemic and Biologic Response to MV
Prior to the initiation of MV, no significant differences existed in body weight between the experimental groups. Importantly, 12 hours of MV did not significantly alter body weight between groups (p < 0.05). In addition, heart rate, systolic blood pressure, Pao 2 , Paco 2 , and pH were all maintained relatively constant during MV, with no significant differences existing between groups ( Table 1 ). In addition, the colonic (body) temperature remained relatively constant (36-37°C) during MV. At the completion of the MV protocol, there was no visible indication of lung injury and no evidence of infection, indicating that our aseptic surgical technique was successful.
Inhibition of FOXO Attenuates VIDD
To determine if inhibition of FOXO transcription protects against VIDD, we measured diaphragm muscle-specific force production and diaphragm muscle fiber CSA. Similar to published reports, 12 hours of MV resulted in a significant reduction in diaphragm muscle force production. Importantly, treatment of control animals with dnFOXO resulted in no significant differences in diaphragm force production compared with control animals. Finally, treatment of MV animals with dnFOXO prevented the VIDD-associated decrease in diaphragm-specific force production (Fig. 1A) .
Diaphragm muscle CSA was also maintained in mechanically ventilated animals treated with dnFOXO compared with control animals (Fig. 1B) . Specifically, 12 hours of MV resulted in a significant reduction in muscle fiber CSA, and treatment of mechanically ventilated animals with dnFOXO prevented the MV-induced diaphragm atrophy. In addition, treatment of control animals with dnFOXO did not result in any significant changes compared with the empty vector-injected control animals.
FOXO Inhibition Protects Against MV-Induced Alterations to Diaphragm Ultrastructure
Electron microscopy images were obtained to visualize alterations to diaphragm ultrastructure that occur as a result of MV. Visual analysis of diaphragm muscle images from MV animals revealed 1) damage to the sarcomeric structure (Fig. 2A) ; 2) an accumulation of lipid droplets (Fig. 2B); 3) increased apoptotic mitochondria (Fig. 2C) ; and 4) increased formation of autophagic vacuoles (Fig. 2D) . Administration of dnFOXO to mechanically ventilated animals maintained myofibrillar stability, organization of mitochondrial structure, and reduced vacuole formation within the muscle. However, dnFOXO appeared to have no effect on the formation of lipid droplets in the diaphragm.
FOXO-Dependent Regulation of the UbiquitinProteasome System During MV
Atrogin-1/MaFbx and MuRF-1 are two muscle-specific E3 ligases that are transcriptionally induced by FOXO. In this regard, our data demonstrate that MV results in a significant increase in the messenger RNA (mRNA) expression of both Atrogin-1/MaFbx and MuRF-1 and that inhibition of FOXOspecific translation results in an attenuation of these increases (p < 0.05). However, expression of Atrogin-1/MaFbx was still elevated compared to control animals (Fig. 3, A and B) . Finally, we also measured the chymotrypsin-like activity of the 20S proteasome. Our results demonstrate that MV results in a significant increase in the activity of the 20S proteasome. However, this increase is significantly attenuated when FOXO activity is blocked (p < 0.05) (Fig. 3C) .
FOXO-Dependent Regulation of the Autophagy/ lysosomal System During MV
The autophagy/lysosomal system is responsible for the degradation of long-lived proteins, organelles, and bulk cytoplasm by the formation of double membrane vesicles called "autophagosomes," whose contents are degraded by lysosomal proteases (22) . Initiation of autophagosome formation begins with the activation of the phosphoinositide 3-kinase complex Beclin-1/ Vps34/Vps15. Prolonged MV increases the mRNA expression of Beclin-1 in the diaphragm, which is significantly attenuated in the MV-dnFOXO animals (p < 0.05) (Fig. 4A) . However, no differences existed in the protein expression of Beclin-1 in the diaphragm between groups (Fig. 4B) . We also measured the diaphragm protein expression of the antiapoptotic protein Bcl-2, which forms a complex with Beclin-1 to inhibit autophagy. Our results demonstrate a significant reduction in the protein levels of Bcl-2 in the MV group compared with control and MV-dnFOXO animals (p < 0.05) (Fig. 4C) .
LC3 also plays an important role in autophagosome formation and is transcriptionally regulated by FOXO. Our data demonstrate that MV results in a significant increase in the mRNA expression of LC3 as well as the ratio of LC3II to LC3I in the diaphragm. In addition, MV also causes an increase in the appearance of LC3 punctae in diaphragm muscle cross-sections. However, administration of dnFOXO to the diaphragm of animals prior to MV results in a significant attenuation in the mRNA expression of LC3 (p < 0.05) as well as the appearance of LC3 punctae (Fig. 5A-C) .
Finally, cathepsins are lysosomal proteases essential for degradation of the contents of the autophagosome. Specifically, cathepsin L has been demonstrated to be active in the diaphragm during MV and is also under transcriptional control of FOXO. Our data reveal that cathepsin L activity and mRNA expression in the diaphragm is significantly increased following 12 hours of MV compared to control, and treatment with dnFOXO resulted in a significant reduction of cathepsin L activity compared to MV. However, mRNA expression of cathepsin L remained elevated compared to control (p < 0.05) (Fig. 6, A and B) .
FOXO-Dependent Alterations to MV-Induced Mitochondrial Function and Apoptosis
It has been demonstrated that MV results in diaphragmatic mitochondrial dysfunction and increased apoptosis (9, 21) . Our results confirm these findings as prolonged MV resulted in a significant decrease in the RCR of diaphragm mitochondria ( Table 2 ) and a significant increase in caspase-3 activity (Fig. 7B) . However, our results demonstrate that inhibiting FOXO transcription in the diaphragm during prolonged MV is sufficient to protect mitochondrial function as well as prevent caspase-3 activation. In regard to FOXO transcription, the proapoptotic mitochondrial protein BNIP3 is a known target of FOXO. Our results demonstrate that inhibiting FOXO transcription in the diaphragm during MV results in a significant reduction in the mRNA expression of BNIP3 and BNIP3L compared with MV animals (Fig. 7, C and D) . In addition, dnFOXO also results in a significant reduction in the MV-induced increases in cytosolic cytochrome c protein levels as well as the appearance of TUNEL-positive nuclei in the diaphragm (Figs. 7E and 8) .
DISCUSSION
These experiments provide new and important information regarding the role that FOXO signaling plays in VIDD. Our results reveal that MV-induced increases in FOXO signaling are sufficient to contribute to diaphragm atrophy and contractile dysfunction. Specifically, activity of the FOXO family of transcription factors contributes to VIDD, at least in part, by increasing the expression of proteins required for the activation of the ubiquitin-proteasome system, the autophagy/lysosomal system, and caspase-3. A detailed discussion of these findings follows.
MV-Induced Contractile Dysfunction and Atrophy Are linked to FOXO Transcription
The FOXO family of transcription factors play a significant role during various conditions that promote skeletal muscle atrophy (15, 23, 24) . Although four FOXO family members exist in mammalian cells, only FOXO1, FOXO3a, and FOXO4 are present in skeletal muscle. In this regard, only FOXO1 and FOXO3a have been shown to increase during conditions that promote skeletal muscle wasting (i.e., fasting, cancer cachexia, disuse, MV, and aging) (15) . In this regard, it has been demonstrated that inhibition of FOXO transcriptional activity during immobilization-induced skeletal muscle wasting results in prevention of almost half of the inactivity-induced muscle fiber atrophy (24) . Similarly, other groups have demonstrated a requirement for FOXO activity in limb muscle atrophy (16, 23, 25, 26) . Importantly, the current experiments provide the first evidence that MV-induced diaphragm atrophy and contractile dysfunction are significantly attenuated when FOXO transcription is inhibited. However, disruption to sarcolemmal morphology and permeability, calcium homeostasis and release, or contractile protein concentrations may be responsible for the observed incomplete preservation of diaphragm-specific force production compared to CSA.
Mechanisms of FOXO Activation
Although it is well established that FOXO is necessary for skeletal muscle atrophy during many conditions, the mechanisms leading to FOXO activation are not well defined. In this regard, it has been demonstrated that increased oxidative stress is an upstream regulator of FOXO signaling (27) , and Hussain et al (8) recently hypothesized that both the autophagic and ubiquitin-proteasome-mediated protein degradation are triggered by oxidative stress and the up-regulation of FOXO.
Additionally, FOXO is activated through alterations to protein kinase B (AKT) phosphorylation. During basal conditions, FOXO is targeted for phosphorylation by AKT, which results in reductions in transcriptional activity (8) . Inhibition of AKTmediated phosphorylation mobilizes FOXO factors to the nucleus where they induce gene expression (16, 23, 28) . In this context, numerous studies of both animal and human patients suggest that MV alters AKT phosphorylation status (8, 11, 12) .
Finally, Beharry et al (29) recently demonstrated that FOXO acetylation status may also regulate FOXO transcriptional activity. These new findings suggest that FOXO is repressed under normal conditions by reversible lysine acetylation, and deacetylation of FOXO is sufficient to induce muscle atrophy (29) .
Activation of the Ubiquitin-Proteasome System by FOXO
The ubiquitin-proteasome system is activated in skeletal muscle to remove sarcomeric proteins during periods of accelerated proteolysis. Although the importance of the E3 (8, 9, 20, 33) . Finally, during experimental conditions (i.e., antioxidant administration) where their expression is preserved at control levels, MV-induced diaphragm atrophy and contractile dysfunction are ameliorated (9, 20, 34) . Therefore, it is feasible that the expression of the E3 ligases may contribute to the development of VIDD.
MV-Induced Activation of the Autophagy/lysosomal System in the Diaphragm Is Regulated by FOXO
In skeletal muscle, autophagy is a constitutively active process that is strongly induced during fasting, oxidative stress, and denervation, resulting in significant muscle protein degradation (23, 28, 35, 36) . Hussein et al (8) were the first to report the appearance of autophagosomes in the diaphragm of MV patients, which was coincident with the significant induction of autophagyrelated genes. However, the factors controlling the activation of these genes during MV have not been determined. In this context, our data demonstrate a significant induction of autophagy in the diaphragm during prolonged MV, which is inhibited if FOXO activation is knocked down. Specifically, the autophagy genes-LC3, BNIP3, and cathepsin L-are established FOXO target genes (16, 23, 37, 38) . More importantly, our results reveal that prolonged MV promotes a significant increase in the expression of these genes in the diaphragm, and this expression was attenuated in animals treated www.ccmjournal.org e141 with dnFOXO. In addition, knockdown of FOXO was also sufficient to attenuate the increased appearance of LC3 punctae as well as autophagic vacuoles within the diaphragm muscle fibers. Together, these findings indicate that FOXO-specific transcription of autophagy genes appears to play a significant role in increased autophagy in the diaphragm during MV.
Inhibition of FOXO Transcription Attenuates MVInduced Mitochondrial Dysfunction in the Diaphragm
Prolonged MV results in VIDD due to increased mitochondrial reactive oxygen species emission, which serves as a signal for activation of numerous proteolytic systems. Specifically, previous data demonstrate that mitochondria from the diaphragm of mechanically ventilated animals exhibit respiratory dysfunction as evidenced by impaired coupling (i.e., decreased RCR) (9, 21, 33) . Damage to mitochondria can result in the enhancement of ROS production at complexes I and III (21) . In addition, damage to mitochondria ultrastructure can alter mitochondrial membrane potential and result in mitochondria destruction due to rupture of the mitochondrial membrane and selective autophagy (i.e., mitophagy) of damaged mitochondria.
BNIP3 is transcriptionally regulated by FOXO and can contribute to mitochondrial damage (39, 40) . Specifically, BNIP3 and its homolog BNIP3L are members of a subfamily of Bcl-2-related proteins that regulate apoptosis from both mitochondrial and nonmitochondrial sites by selective Bcl-2/Bcl-xL interactions. Under normal conditions, endogenous BNIP3 is loosely associated with the mitochondrial membrane, but during conditions of cell stress, BNIP3 fully integrates into the mitochondrial outer membrane, leading to mitochondrial dysfunction that is characterized by opening of the mitochondrial permeability transition pore. Therefore, increased transcription of BNIP3/BNIP3L may contribute to MV-induced mitochondrial dysfunction. In addition, our data also show an MV-induced increase in cytochrome c release, caspase-3 activity, and the appearance of TUNEL-positive nuclei, which are indicative of myonuclear apoptosis in the diaphragm. Importantly, inhibition of FOXO rescued the diaphragm from MV-induced mitochondrial dysfunction potentially due to a reduction in autophagic and apoptotic signaling.
CONClUSIONS
VIDD is an important clinical problem that contributes to morbidity and mortality outcomes in patient populations experiencing weaning difficulties. This investigation provides the first evidence that increased transcription of atrophyrelated genes by FOXO is necessary for the activation of key proteolytic systems essential for MV-induced diaphragm atrophy and contractile dysfunction. In the current study, inhibition of FOXO-specific transcription resulted in significant attenuation of target genes. However, mRNA levels of both Atrogin-1/MaFbx and Cathepsin L in the diaphragm remained elevated compared to controls. Therefore, it appears that these genes can be regulated through an alternate signaling pathway, and this hypothesis warrants future exploration. Finally, although there are currently no clinically approved methods for targeting FOXO transcription due to the numerous cellular functions of FOXO, further insight into the function of FOXO in various disease states is essential to provide further understanding for the use of FOXO antagonists in clinical practice. 
